PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression

Authors:: Neera Yadav; Amit Kumar Tripathi; Amna Parveen; Shama Parveen; Monisha Banerjee

Reference:: Pharmaceutics; 2022; 14; 1326

DOI:: 10.3390/pharmaceutics14071326

See Abstract

Key Words:: Quercetin; PLGA nanoparticles; PI3K/AKT; FoxO1; caspase; mammary adenocarcinoma; rats; animal experiments

Back to index